Nutritional Deficiencies Seen in Youth Taking GLP-1 Receptor Agonists

THURSDAY, Sept. 24, 2026 (HealthDay News) -- Nutritional deficiencies are a common and underrecognized risk among pediatric patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment, according to a study published online Sept. 17 in Childhood Obesity.Kirk W. Kerr, Ph.D., from Abbott Nutrition in Columbus, Ohio, and colleagues examined nutritional deficiency incidence and use of nutrition therapy/counseling among pediatric GLP-1 RA users. The analysis included 2,031 GLP-1 RA users aged 10 to 17 years identified from the Inovalon administrative claims data (2017 to 2022); 62.6 percent had obesity.The researchers found that liraglutide (78.6 percent), dulaglutide (10.4 percent), and semaglutide (9.1 percent) were the most prescribed GLP-1 RA drugs. Within one year of use, 16.88 percent of patients were diagnosed with at least one nutritional deficiency or deficiency-related complication, including most frequently vitamin D deficiency (12.4 percent), followed by nutritional anemia (1.55 percent) and iron-deficiency anemia (1.44 percent). Within 180 days, only 23.3 percent had a nutrition therapy/counseling visit (mean time to first visit, 149 days). There were higher rates of nutritional deficiencies and deficiency-related complications observed among patients with nutrition therapy/counseling consultations versus those without (23.2 versus 14.8 percent)."We hope that our study findings bring much needed recognition to the importance of proactive nutritional management when GLP-1s are prescribed to children, as opposed to waiting until a nutritional deficiency is diagnosed," senior author Justin Ryder, Ph.D., from the Northwestern University Feinberg School of Medicine in Chicago, said in a statement. "Knowing the risks, we are in a much better position to prevent harm to children treated with GLP-1s during a pivotal period in their lives."Several authors disclosed financial ties to pharmaceutical companies, including Abbott, which funded the study.Abstract/Full Text .Sign up for our weekly HealthDay newsletter

Nutritional Deficiencies Seen in Youth Taking GLP-1 Receptor Agonists

Related Stories

Most Sports Parents Say There's More Good Than Harm In Youth Sports, Survey Finds

Youth Suicide Risk Linked to Community Firearm Violence

Less Overdiagnosis In Breast Cancer Screening Than Thought, Study Finds

Use of GLP-1 Receptor Agonists Increasing Among Children With Obesity